tofacitinib
pfizer
[]
#acr2022 #acr22 12s102. year in review next to the most discussed study of the year oral surveillance trial the cv risk is higher in those with ascvd - nnh 16 
??Snapshots of #Rheumatology
Visual Abstracts
One stop destination to everything HOT??(How to treat) & WIN(What's???)in Rheumat
#Rheumtwitter
By: @kunalchandwar